Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
What AXA's recent performance tells you
AXA (ENXTPA:CS) has drawn investor attention after recent share price moves, with the stock around €41.58 and mixed short term returns that contrast with stronger multi year performance, as well as solid reported revenue and net income figures.
See our latest analysis for AXA.
The recent 1 day share price return of a 0.53% decline sits against a 90 day share price return of 4.84% and a 5 year total shareholder return of 133.59%. This suggests that momentum has built over longer periods despite short term pullbacks.
If AXA's recent moves have you thinking about what else is out there, this is a good moment to broaden your search with the 100 top founder-led companies
So with AXA trading around €41.58, solid reported revenue and net income, and an indicated intrinsic discount of about 54%, should you view the stock as undervalued, or is the market already pricing in future growth?
Most Popular Narrative: 9.7% Undervalued
Against AXA's last close of €41.58, the most followed narrative points to a fair value of about €46.07, using a 6.57% discount rate and detailed earnings assumptions.
The rejuvenation and positive net flows in Life & Savings, driven by product innovations and better persistency, are expected to convert into higher Contractual Service Margin (CSM) release and sustained earnings growth as the aging global population increases demand for retirement and protection products.
Curious what sits behind that fair value gap? The narrative leans on specific revenue growth, margin shifts and future earnings multiples that are not immediately obvious from the headline numbers.
Result: Fair Value of €46.07 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, currency swings and softer reinsurance pricing could quickly eat into reported earnings and challenge the assumptions behind that €46.07 fair value narrative.
Find out about the key risks to this AXA narrative.
Next Steps
With mixed signals on valuation, risks and rewards, this is a moment to look through the details yourself and decide where you stand, starting with the 3 key rewards and 1 important warning sign
Looking for more investment ideas?
If AXA has sharpened your focus, do not stop here. Broaden your watchlist now so you do not miss other opportunities taking shape across the market.
-
Spot underpriced quality by checking companies that screen as resilient and attractively valued with the 227 high quality undervalued stocks
-
Strengthen your income stream by reviewing stocks that pass the yield and resilience tests in the 483 dividend fortresses
-
Get ahead of the crowd by scanning lesser known companies with solid fundamentals through the screener containing 547 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CS.PA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
